RCUS - Arcus Biosciences Inc
Close
17.12
-0.210 -1.227%
Share volume: 436,621
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$17.33
-0.21
-1.21%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-03 | 2022-11-02 | 2023-02-28 | 2023-05-09 | 2023-08-07 | 2023-11-07 | 2024-02-21 | 2024-05-08 | |
| Total revenue | 26.759 M | 33.581 M | 33.655 M | 25.000 M | 29.000 M | 32.000 M | 31.000 M | 145.000 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 26.759 M | 33.581 M | 33.655 M | 25.000 M | 29.000 M | 32.000 M | 31.000 M | 145.000 M | |
| 25.49% | 0.22% | -25.72% | 16.00% | 10.34% | -3.13% | 367.74% | |||
| Operating expenses | 95.741 M | 102.978 M | 108.096 M | 111.000 M | 112.000 M | 112.000 M | 122.000 M | 141.000 M | |
| Selling general and admin | 25.836 M | 26.294 M | 27.896 M | 30.000 M | 28.000 M | 30.000 M | 29.000 M | 32.000 M | |
| Research and development | 69.905 M | 76.684 M | 80.200 M | 81.000 M | 84.000 M | 82.000 M | 93.000 M | 109.000 M | |
| Total expenses | 95.741 M | 102.978 M | 108.096 M | 111.000 M | 112.000 M | 112.000 M | 122.000 M | 141.000 M | |
| 7.56% | 4.97% | 2.69% | 0.90% | 0.00% | 8.93% | 15.57% | |||
| Operating income | -68.982 M | -69.397 M | -74.441 M | -86.000 M | -83.000 M | -80.000 M | -91.000 M | 4.000 M | |
| Ebit | -68.982 M | -69.397 M | -74.441 M | -86.000 M | -83.000 M | -80.000 M | -91.000 M | 4.000 M | |
| Pretax income | -66.632 M | -64.919 M | -67.460 M | -78.000 M | -74.000 M | -69.000 M | -80.000 M | -4.000 M | |
| -2.57% | 3.91% | 15.62% | -5.13% | -6.76% | 15.94% | -95.00% | |||
| Income tax | 0.000 | 0.000 | -4.000 K | 2.000 M | 1.000 M | 2.000 M | 1.000 M | 0.000 | |
| Net income basic | -66.632 M | -64.919 M | -67.456 M | -80.000 M | -75.000 M | -71.000 M | -81.000 M | -4.000 M | |
| 2.57% | -3.91% | -18.60% | 6.25% | 5.33% | -14.08% | 95.06% | |||
| Net income | -66.632 M | -64.919 M | -67.456 M | -80.000 M | -75.000 M | -71.000 M | -81.000 M | -4.000 M | |
| 2.57% | -3.91% | -18.60% | 6.25% | 5.33% | -14.08% | 95.06% |